Prof. Dr. Funda CERAN

1. Bidirectional Temporal Association Between Cytomegalovirus Reactivation and Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Real-World Cohort Study

İşleyen E., DAĞDAŞ S., Kayaaslan B., CERAN F., Pepeler M. S., Kaya A., et al.

Viruses , cilt.18, sa.8, 2026 (SCI-Expanded, Scopus)

2. Clinical Spectrum and Differential Diagnosis of Adult Thrombotic Microangiopathies: Real-World Experience from a Tertiary Referral Center

Kırkayak N. P., Ozet G., DAĞDAŞ S., CERAN F., ATEŞ İ.

Hematology Reports , cilt.18, sa.4, 2026 (ESCI, Scopus)

3. Tongue Uptake of 18F-FDG on PET/CT Mimicking Malignancy

Okudan B., Albayrak A., Seven B., CERAN F.

Clinical Nuclear Medicine , cilt.51, sa.5, ss.454-455, 2026 (SCI-Expanded, Scopus)

4. Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G-CSF Treatment in Unrelated Donors

Korkmaz G., Ozet G., CERAN F., Aydın M. S., Pamukcuoglu M., Isleyen E., et al.

Journal of Clinical Apheresis , cilt.41, sa.1, 2026 (SCI-Expanded, Scopus)

5. Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms

Aydin M. S., DAĞDAŞ S., Pepeler M. S., Korkmaz G., Alper A., Açıkgöz E., et al.

International Journal of Endocrinology , cilt.2026, sa.1, 2026 (SCI-Expanded, Scopus)

6. Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center

Aydin M. S., Korkmaz G., Pamukcuoglu M., Guner H. R., CERAN F., DAĞDAŞ S., et al.

Mediterranean Journal of Hematology and Infectious Diseases , cilt.18, sa.1, 2026 (SCI-Expanded, Scopus)

7. Ocular surface and corneal subbasal nerve plexus changes in ocular graft versus host disease patients treated with topical cyclosporine

KARACA E. E., Kemer Ö. E., DAĞDAŞ S., Asfuroğlu Y., CERAN F., Pepeler M. S., et al.

BMC Ophthalmology , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

8. Effectiveness and safety of therapeutic plasma exchange in neurological diseases: An 11-year report from a tertiary care center

Korkmaz G., DAĞDAŞ S., Saltoglu T., CERAN F., Aydın M. S., BEKTAŞ H., et al.

Therapeutic Apheresis and Dialysis , cilt.29, sa.2, ss.312-320, 2025 (SCI-Expanded, Scopus)

9. Is there a relationship between vitamin D levels and graft versus host disease?

YİĞENOĞLU T. N., Ulu B. U., NAMDAROĞLU S., ERKURT M. A., Sahin R., Okumus N., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

10. What Happened Suddenly-Acute Abdomen? A Difficult Case of ATRA-Related Pneumatosis Cystoides Intestinalis Aniden Ne Oldu: Akut Abdomen? ATRA İlişkili Pnömatozis Sistoides İntestinalis Gelişen Zor Olgu

Yön M. E. E., Ceylan A., Kaya E. İ., Ölçücüoğlu E., CERAN F., DAĞDAŞ S., et al.

Turkish Journal of Hematology , cilt.42, sa.2, ss.150-152, 2025 (SCI-Expanded, Scopus, TRDizin)

11. Different Presentations and Different Treatment Options in Blastic Plasmacytoid Dendritic Cell Neoplasms: A Case Series

Cengiz E., Aydin M. S., GÜNEŞ A. K., CERAN F., DAĞDAŞ S., Ozet G.

International Journal of Hematology-Oncology and Stem Cell Research , cilt.19, sa.1, ss.81-85, 2025 (Scopus)

12. Prognostic Role of Neutrophil to Lymphocyte Ratio at Diagnosis in Patients with Diffuse Large B-Cell Lymphoma

Korkmaz G., CERAN F., DAĞDAŞ S., GÜNEŞ A. K., Sunu C., Pepeler M., et al.

Nigerian Journal of Clinical Practice , cilt.27, sa.8, ss.1012-1019, 2024 (SCI-Expanded, Scopus)

13. Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia

Pepeler M. S., Tıglıoglu M., DAĞDAŞ S., Ozhamamcıoglu E., Han U., Albayrak A., et al.

Clinical Lymphoma, Myeloma and Leukemia , cilt.24, sa.4, 2024 (SCI-Expanded, Scopus)

14. Effect of Mobilization Methods on CD34+ and Total Nucleated Cell Count and Their relation with Engraftment in Autologous Hematopoietic Stem Cell Transplantation

Beyler Ö., Pamukcuoğlu M., GÜNEŞ A. K., Korkmaz G., Ulusoy G., CERAN F., et al.

Eastern Journal of Medicine , cilt.29, sa.3, ss.344-348, 2024 (Scopus, TRDizin)

15. Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia ABO Kan Grubu Uyumsuz Allojenik Hematopoetik Kök Hücre Nakli Olan Hastada Gelişen Saf Eritroid Hücre Aplazisinde Daratumumab ve Eltrombopag Kullanımı

Pepeler M. S., DAĞDAŞ S., İşleyen E., Katayıfçı G., Kılıçarslan A., Özhamam E., et al.

Turkish Journal of Hematology , cilt.41, sa.4, ss.288-290, 2024 (SCI-Expanded, Scopus, TRDizin)

16. Comparison of maintenance regimens in Acute Promyelocytic Leukemia patients

Kilic Gunes E., ÖZKURT Z. N., Yildiz S., Ozet G., CERAN F., ALBAYRAK M., et al.

Leukemia Research , cilt.128, 2023 (SCI-Expanded, Scopus)

17. A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry

Ozdemir Z. N., Falay M., Parmaksiz A., Genc E., Beyler O., GÜNEŞ A. K., et al.

Hematology, Transfusion and Cell Therapy , cilt.45, sa.2, ss.176-181, 2023 (ESCI, Scopus)

18. Outcomes of COVID-19 Patients Undergoing Therapeutic Plasma Exchange in Intensive Care Units

Aydin M. S., Pepeler M. S., Akdag A. G., GÖKBULUT BEKTAŞ Ş., ERDEM D., GÖKÇINAR D., et al.

Journal of Critical and Intensive Care , cilt.14, sa.2, ss.41-46, 2023 (ESCI, Scopus, TRDizin)

19. Predictive Factors for Molecular Response in Chronic Myeloid Leukemia: Reduction Ratio and Halving Time of BCR::ABL1 IS Transcript Levels Kronik Myeloid Lösemide Moleküler Yanıtı Öngörücü Faktörler: BCR::ABL1 IS Transkript Seviyelerinin Azalma Oranı ve Yarılanma Zamanı

CERAN F., Akıncı S., Uçar M. A., Korkmaz G., Gündüz M., Çavdarlı B., et al.

Turkish Journal of Hematology , cilt.39, sa.3, ss.196-203, 2022 (SCI-Expanded, Scopus, TRDizin)

20. The evaluation of patients with essential thrombocythemia in terms of risk of thrombosis

Sunu C., GÜNEŞ A. K., Akat G. K., Kalpakci Y., CERAN F., DAĞDAŞ S., et al.

Revista da Associacao Medica Brasileira , cilt.67, sa.3, ss.385-389, 2021 (SCI-Expanded, Scopus)

21. Conditioning Regimens for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Stem Cell Transplantation: BEAM Versus High Dose ICE

GÜNEŞ A. K., DAĞDAŞ S., CERAN F., Ucar M. A., Falay M., Sunu C., et al.

Indian Journal of Hematology and Blood Transfusion , cilt.37, sa.1, ss.82-89, 2021 (SCI-Expanded, Scopus)

22. Comparison of allogenic stem cell transplantations performed with frozen or fresh stem cell products with regard to GVHD and mortality

DAĞDAŞ S., Ucar M. A., CERAN F., GÜNEŞ A. K., Falay M., Ozet G.

Transfusion and Apheresis Science , cilt.59, sa.4, 2020 (SCI-Expanded, Scopus)

23. IS DYNAMIC THIOL/DISULFIDE HOMEOSTASIS ASSOCIATED WITH THE PROGNOSIS OF MYELODYSPLASTIC SYNDROME? POVEZANOST DINAMICNE TIOL/DISULFIDNE HOMEOSTAZE SA PROGNOZOM MIJELODISPLAZNOG SINDROMA

Ucar M. A., Tombak A., DAĞDAŞ S., Akdeniz A., CERAN F., NEŞELİOĞLU S., et al.

Journal of Medical Biochemistry , cilt.39, sa.3, ss.336-345, 2020 (SCI-Expanded, Scopus)

24. Aspergillus and nocardia coinfection in a patient with allogeneic stem cell transplantation Alojenik kök hücre nakli yapılan bir hastada aspergillus ve nocardia koinfeksiyonu

Araz H., Kocagül-çelikbaş A., HAZIROLAN G., DAĞDAŞ S., CERAN F., Taşpınar E., et al.

Klimik Dergisi , cilt.32, sa.2, ss.195-199, 2019 (Scopus)

25. A multi-center study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia: A real-life experience Refrakter kronik immün trombositopeni tedavisinde eltrombopagın etkinliğine ilişkin çok merkezli bir çalışma: Gerçek yaşam deneyimi

Çekdemir D., Güvenç S., Özdemirkıran F., Eser A., TOPTAŞ T., ÖZKOCAMAN V., et al.

Turkish Journal of Hematology , cilt.36, sa.4, ss.230-237, 2019 (SCI-Expanded, Scopus, TRDizin)

26. The importance of RET-He in the diagnosis of iron deficiency and iron deficiency anemia and the evaluation of response to oral iron therapy

Uçar M. A., Falay M., DAĞDAŞ S., CERAN F., Urlu S. M., Özet G.

Journal of Medical Biochemistry , cilt.38, sa.4, ss.496-502, 2019 (Scopus)

27. The role of CD200 and CD43 expression in differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma Kronik lenfositik lösemi ve mantle hücreli lenfoma ayırıcı tanısında cd200 ve cd43 ekspresyonunun rolü

Falay M., Öztürk B. A., Güneş K., Kalpakçı Y., DAĞDAŞ S., CERAN F., et al.

Turkish Journal of Hematology , cilt.35, sa.2, ss.94-98, 2018 (SCI-Expanded, Scopus, TRDizin)

28. The assessment of CD56 and CD117 expressions at the time of the diagnosis in multiple myeloma patients Multipl Miyeloma Hastalarında Tanı Sırasında CD56 ve CD117 Ekspresyonlarının Değerlendirilmesi

CERAN F., Falay M., DAĞDAŞ S., Özet G.

Turkish Journal of Hematology , cilt.34, sa.3, ss.226-232, 2017 (SCI-Expanded, Scopus, TRDizin)

29. Determination of HLA-G Expression and Evaluation of Its Role as a Prognostic Factor in Chronic Lymphocytic Leukemia

Ozet G., Falay M., DAĞDAŞ S., CERAN F.

Journal of Clinical Laboratory Analysis , cilt.30, sa.5, ss.399-403, 2016 (SCI-Expanded, Scopus)

30. Clinical significance of CD87 expression in acute myeloblastic leukemia Akut miyeloblastik lösemide CD87 ekspresyonunun klinik önemi

CERAN F., Ozet G., DAĞDAŞ S., Falay M., ALBAYRAK M., Yokus O., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.26, sa.1, ss.47-53, 2016 (SCI-Expanded, Scopus, TRDizin)

31. CD38 expression and variation as a prognostic factor chronic lymphocytic leukemia

Falay M., CERAN F., GÜNEŞ A. K., DAĞDAŞ S., AYLI M., Ozet G.

Clinical Laboratory , cilt.62, sa.7, ss.1287-1293, 2016 (SCI-Expanded, Scopus)

32. Conventional cytogenetics and fish [del13q, del17p, t(11;14), t(4;14)] findings and their relationship with other risk factors in multiple myeloma Multipl myelomda konvansiyonel sitogenetik ve fish [del13q, del17p, t(11;14), t(4;14)] bulgulari ve diǧer risk faktörleri ile Iliflkisi

Balcik O. S., ALBAYRAK M., DAĞDAŞ S., Helvaci N., Yokus O., CERAN F., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.21, sa.4, ss.203-209, 2011 (SCI-Expanded, Scopus, TRDizin)

33. Serum thrombin activatable fibrinolysis inhibitor levels in patients with newly diagnosed multiple myeloma

Balcik O. S., ALBAYRAK M., Uyar M. E., DAĞDAŞ S., Yokus O., CERAN F., et al.

Blood Coagulation and Fibrinolysis , cilt.22, sa.4, ss.260-263, 2011 (SCI-Expanded, Scopus)

34. Assessment of plasma endostatin levels in patients with acute myeloblastic and lymphoblastic leukemia Akut myeloblastik ve lenfoblastik lösemili hastalarda plazma endostatin düzeylerinin deǧerlendirilmesi

DAĞDAŞ S., Ozet G., Yilmaz M., ALBAYRAK M., CERAN F.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.21, sa.4, ss.210-216, 2011 (SCI-Expanded, Scopus, TRDizin)

35. A rare extramedullar involvement in myeloma: Lung parenchyma and association with unfavorable chromosomal abnormalities Miyelom'da nadir bir ekstramedüller tutulum: Akciǧer parankimi ve olumsuz kromozomal anormalliklerle ilişkisi

Balçik Ö. Ş., ALBAYRAK M., DAĞDAŞ S., CERAN F., Özet G., DEMİRAĞ F., et al.

Turkish Journal of Hematology , cilt.27, sa.2, ss.109-112, 2010 (Scopus, TRDizin)

36. Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis Serebral venöz tromboz geçiren hastaların trombofilik risk faktörleri açisından deǧerlendirilmesi

Yokşu O., Balçik Ö. Ş., ALBAYRAK M., CERAN F., DAĞDAŞ S., Yilmaz M., et al.

Turkish Journal of Hematology , cilt.27, sa.3, ss.162-167, 2010 (Scopus, TRDizin)

37. A case of multicentric HHV-8 positive Castleman's disease presenting with marked lymphocytosis

DAĞDAŞ S., ALBAYRAK M., Balçik Ö. Ş., Özet G., CERAN F., Erekul S.

Turkish Journal of Cancer , cilt.39, sa.3, ss.110-114, 2009 (Scopus)

38. Risk factors for thrombophilia in young adults presenting with thrombosis

Yokus O., ALBAYRAK M., Balcik O. S., CERAN F., DAĞDAŞ S., Yilmaz M., et al.

International Journal of Hematology , cilt.90, sa.5, ss.583-590, 2009 (SCI-Expanded, Scopus)

39. Development of multiple myeloma in the course of chronic lymphocytic leukemia: Case report Kronik lenfositik lösemi seyrinde multipl miyelom gelişimi: Olgu sunumu

Balçik Ö. Ş., DAĞDAŞ S., ALBAYRAK M., Efe C., Yokuş O., CERAN F., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.18, sa.4, ss.238-241, 2008 (Scopus, TRDizin)

40. An unusual case of spontaneous acute tumor lysis syndrome associated with acute lymphoblastic leukemia: A case report and review of the literature [3]

Akoz A. G., Yildirim N., Engin H., DAĞDAŞ S., Ozet G., Tekin I. O., et al.

Acta Oncologica , cilt.46, sa.8, ss.1190-1192, 2007 (SCI-Expanded, Scopus)

41. Isolated central nervous system relapse during cytologic and molecular hematologic remission in two patients with acute promyelocytic leukemia

Akoz A. G., DAĞDAŞ S., Ozet G., CERAN F., Yilmaz M.

Hematology , cilt.12, sa.5, ss.419-422, 2007 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim